Prostaglandin E2 regulates Th17 cell differentiation and function through cyclic AMP and EP2/EP4 receptor signaling

Area of Science:

• Immunology
• Inflammation research
• T cell biology

Background:

• Prostaglandins, especially prostaglandin E2 (PGE2), are key mediators in inflammation.
• Cyclooxygenase 2 inhibitors, targeting PGE2 synthesis, are used as anti-inflammatory drugs.

Purpose of the Study:

• To investigate the direct role of PGE2 in the differentiation and function of T helper 17 (Th17) cells.
• To elucidate the signaling pathways and receptors involved in PGE2-mediated effects on Th17 cells.

Main Methods:

• Analysis of human and murine naive T cells.
• Assessment of gene and protein expression (IL-23, IL-1 receptor, ROR-gammat, IL-17, IL-17F, CCL20, CCR6, IFN-gamma, IL-10).
• Investigation of signaling pathways involving prostaglandin receptors (EP2, EP4) and cyclic AMP.

Main Results:

• PGE2 up-regulates IL-23 and IL-1 receptor expression in naive T cells via EP2/EP4 and cyclic AMP.
• PGE2 synergizes with IL-1beta and IL-23 to promote Th17 cell differentiation markers.
• PGE2 differentially regulates IFN-gamma and inhibits IL-10 production in Th17 cells, primarily through EP4.

Conclusions:

• PGE2 directly drives Th17 cell differentiation and pro-inflammatory functions.
• The inflammatory microenvironment, including PGE2, critically shapes Th17 cell phenotype and regulation.
• PGE2 influences Th17 cell responses through distinct receptor-mediated pathways, impacting cytokine profiles.